Killick M.
University of the Witwatersrand
Zambia
About
No AI summary yet.
Metrics
- Publications
- 11
- Citations
- 119
- h-index
- 6
- Publishing journals
- 9
- Years of publications
- 15
- Active since
- 2008
- References
- 495
- Institutions
- 1
Publication history
Latest publications
- HIV-1 bispecific antibody iMab-N6 exhibits enhanced breadth but not potency over its parental antibodies iMab and N6
- Immunization with HIV-1 trimeric SOSIP.664 BG505 or founder virus C (FVCEnv) covalently complexed to two-domain CD4S60C elicits cross-clade neutralizing antibodies in New Zealand white rabbits
- Covalent binding of human two-domain CD4 to an HIV-1 subtype C SOSIP.664 trimer modulates its structural dynamics
- Engineering and characterising a novel, highly potent bispecific antibody iMab-CAP256 that targets HIV-1
- Thioredoxin (Trx1) regulates CD4 membrane domain localization and is required for efficient CD4-dependent HIV-1 entry
- Env–2dCD4S60C complexes act as super immunogens and elicit potent, broadly neutralizing antibodies against clinically relevant human immunodeficiency virus type 1 (HIV-1)
- Founder virus envelope glycoproteins as novel oligomeric HIV-1 vaccine immunogens
- Disulfide Reduction in CD4 Domain 1 or 2 Is Essential for Interaction with HIV Glycoprotein 120 (gp120), which Impairs Thioredoxin-driven CD4 Dimerization
- Generation and characterization of an HIV-1 subtype C transmitted and early founder virus consensus sequence
- Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchange
- Short hairpin RNA-directed knockdown of epidermal growth factor receptor in human oesophageal squamous carcinoma cell lines
No publications in the index yet.